Bottom line
Is GURU a good fund? The bottom line
GURU is an index global stock ETF from Global X.
Annual fees run 0.75% — about $75 a year on every $10,000 invested, cheaper than 74% of global stock funds we track.
It returned +25.3% over one year, +7.6% a year over five years, +11.0% a year over ten (as of Dec 31, 2025, per its prospectus).
With $61.2 million in net assets and 88 holdings, its largest position is Corcept Therapeutics Incorporated (2.3%) and the top 10 make up 16.2% of the portfolio.
Updated Nov 19, 2026
What GURU invests in
"The Global X Guru Index ETF (the ""Fund"") seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Guru Index (the ""Underlying Index"")."
"The Fund invests at least 80% of its total assets in the securities of the Solactive Guru Index (the ""Underlying Index"") and in American Depositary Receipts (""ADRs"") and Global Depositary Receipts (""GDRs"") based on the securities in the Underlying Index. The Fund's 80% investment policy is non-fundamental and requires 60 days prior written notice to shareholders before it can be changed. The Fund may lend securities representing up to one-third of the value of the Funds total assets (including the value of the collateral received). The Underlying Index is comprised of the top U.S. listed equity positions reported on Form 13F by a select group of entities characterized as hedge funds, as defined by Solactive AG, the provider of the Underlying Index (the ""Index Provider""). Hedge funds are selected by the Index Provider from a pool of thousands of privately offered pooled…
From the fund's prospectus (filed Feb 26, 2026).
GURU performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| GURU | +25.3% | +7.6% | +11.0% |
| Global Stock median | +15.2% | +7.6% | +9.5% |
Source: Fund prospectus, as of Dec 31, 2025
What GURU costs
On a $10,000 investment, GURU's 0.75% expense ratio costs about $75 a year. The prospectus estimates $930 in total costs over 10 years (assuming 5% annual returns). The median global stock fund charges 0.95%.
GURU top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Corcept Therapeutics Incorporated | 2.26% |
| 2 | Apogee Therapeutics Inc | 1.86% |
| 3 | Immunovant Inc | 1.59% |
| 4 | Lithia Motors, Inc. | 1.59% |
| 5 | Astera Labs Inc | 1.57% |
| 6 | Natera, Inc. | 1.52% |
| 7 | Expedia Group, Inc. | 1.49% |
| 8 | Arcutis Biotherapeutics Inc | 1.46% |
| 9 | United Airlines Holdings, Inc. | 1.43% |
| 10 | Travere Therapeutics, Inc. | 1.42% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 16.2% of the fund. See all top 25 holdings and asset mix →